| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Physically Interacts with CCAAT/Enhancer Binding Protein (C/EBPß) to Inhibit C/EBPß-Responsive
1-Acid Glycoprotein Gene Expression
Laboratoire de Biochimie et de Biologie Cellulaire (A.M., A.B., D.P., N.M.-C.), Equipe dAccueil de Doctorants 1595, Faculté de Pharmacie, Université Paris XI, France; Plate-forme Transcriptome-Protéome (C.D.), Institut National de la Santé et de la Recherche Médicale, Institut Fédératif de Recherche-75, Faculté de Pharmacie, Université Paris XI, France
Address all correspondence and requests for reprints to: Najet Mejdoubi-Charef, Laboratoire de Biochimie et de Biologie Cellulaire, Equipe dAccueil de Doctorants 1595, Tour D4 1erétage, Faculté de Pharmacie, 5 rue J. B. Clément, 92296
Ch
atenay-Malabry Cedex, France. E-mail: najet.charef{at}cep.u-psud.fr.
Recently, the role of the peroxisome proliferator-activated receptor
(PPAR
) in the hepatic inflammatory response has been associated to the decrease of acute phase protein transcription, although the molecular mechanisms are still to be elucidated. Here, we were interested in the regulation by Wy-14643 (PPAR
agonist) of
1-acid glycoprotein (AGP), a positive acute phase protein, after stimulation by Dexamethasone (Dex), a major modulator of the inflammatory response. In cultured rat hepatocytes, we demonstrate that PPAR
inhibits at the transcriptional level the Dex-induced AGP gene expression. PPAR
exerts this inhibitory effect by antagonizing the CCAAT/enhancer binding protein (C/EBPß) transcription factor that is involved in Dex-dependent up-regulation of AGP gene expression. Overexpression of C/EBPß alleviates the repressive effect of PPAR
, thus restoring the Dex-stimulated AGP promoter activity. Furthermore, glutathione-S-transferase GST pull-down and coimmunoprecipitation experiments evidenced, for the first time, a physical interaction between PPAR
and the C-terminal DNA binding region of C/EBPß, thus preventing it from binding to specific sequence elements of the AGP promoter. Altogether, these results provide an additional molecular mechanism of negative regulation of acute phase protein gene expression by sequestration of the C/EBPß transcription factor by PPAR
and reveal the high potency of the latter in controlling inflammation.
NURSA Molecule Pages Link:
This article has been cited by other articles:
![]() |
L. Brunelli, K. A. Cieslik, J. L. Alcorn, M. Vatta, and A. Baldini Peroxisome Proliferator-Activated Receptor-{delta} Upregulates 14-3-3{epsilon} in Human Endothelial Cells via CCAAT/Enhancer Binding Protein-{beta} Circ. Res., March 16, 2007; 100(5): e59 - e71. [Abstract] [Full Text] [PDF] |
||||
![]() |
Q. Yang, R. Kurotani, A. Yamada, S. Kimura, and F. J. Gonzalez Peroxisome Proliferator-Activated Receptor {alpha} Activation during Pregnancy Severely Impairs Mammary Lobuloalveolar Development in Mice Endocrinology, October 1, 2006; 147(10): 4772 - 4780. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. Venteclef, J. C. Smith, B. Goodwin, and P. Delerive Liver receptor homolog 1 is a negative regulator of the hepatic acute-phase response. Mol. Cell. Biol., September 1, 2006; 26(18): 6799 - 6807. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. P. Hewitt, P. J. Mark, and B. J. Waddell Placental Expression of Peroxisome Proliferator-Activated Receptors in Rat Pregnancy and the Effect of Increased Glucocorticoid Exposure Biol Reprod, January 1, 2006; 74(1): 23 - 28. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Endocrinology | Endocrine Reviews | J. Clin. End. & Metab. |
| Molecular Endocrinology | Recent Prog. Horm. Res. | All Endocrine Journals |